BioPorto A/S (CPH:BIOPOR)
0.8750
+0.0150 (1.74%)
Mar 26, 2026, 11:58 AM CET
BioPorto Market Cap
BioPorto has a market cap or net worth of 425.78 million as of March 26, 2026. Its market cap has decreased by -36.23% in one year.
Market Cap
425.78M
Enterprise Value
406.53M
Revenue
36.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.88
Market Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 425.78M, an increase of 465.61%. That is a compound annual growth rate of 8.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 425.78M | -15.69% |
| Dec 30, 2025 | 505.00M | -24.17% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.05T |
| Genmab | 102.68B |
| Coloplast | 97.52B |
| ALK-Abelló | 44.25B |
| Gubra | 5.88B |
| ChemoMetec | 4.88B |
| Pharma Equity Group | 104.59M |
| ViroGates | 103.49M |